Type 2 Diabetes Trial, Recruiting NCT01945840 Sponsor: Imperial College London Condition: Type 2 Diabetes
Back to Type 2 Diabetes

Type 2 Diabetes Trial, Recruiting

NCT01945840
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 18 and 70 years old.
  • People of any gender.
  • People who meet the NHS criteria for weight-loss (bariatric) surgery.
  • People who have been diagnosed with either prediabetes (impaired glucose regulation) or type 2 diabetes, based on World Health Organization guidelines from 2011.
  • People with diabetes whose condition is stable and managed through diet alone or with a single diabetes tablet (not insulin).
  • People whose HbA1c blood sugar level (a measure of average blood sugar over several months) is at or below 9.0% (or 74.9 mmol/mol).

Who may not be able to join:

  • People with a medical, psychological, or other condition — or who take any medications, including over-the-counter products — that the trial investigators believe could interfere with the study or cause harm.
  • People who do not have access to a telephone at home, or who have other circumstances likely to make reliable participation difficult.
  • People who are pregnant or breastfeeding.
  • People who smoke.
  • People who are unable to use reliable contraception throughout the study and for one month after it ends.
  • People who have had an allergic reaction to any ingredients used in the under-the-skin (subcutaneous) infusions involved in the study.
  • People who have donated blood in the three months before joining, or who plan to donate blood before the study ends.
  • People who currently use insulin to manage their diabetes.
  • People with high blood pressure that is not well controlled.
  • People with other serious health conditions that could affect the safety of the study or its results, such as heart failure or known cardiovascular (heart and blood vessel) disease.
  • People taking blood-thinning medications such as warfarin or factor Xa inhibitors will not be able to take part in the fat tissue biopsy (a minor procedure to collect a small sample of fatty tissue).
  • People who are unable to give informed consent to participate.
  • People who have previously had bariatric (weight-loss) surgery.
  • People who are unable to undergo an fMRI brain scan, including those who:
    • Experience claustrophobia (fear of enclosed spaces).
    • Have a pacemaker, metal implants, clips, implanted devices, shrapnel, bullets, or metal fragments in the eyes that are not compatible with magnetic resonance imaging.
    • Have a significant abnormality found on a brain MRI scan.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 October 2013
Est. completion
31 October 2028

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

Weight loss

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov